Back to search

Article

A targeted, low-throughput compound screen in a <i>Drosophila</i> model of neurofibromatosis type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD)

2022-11-13

Abstract excerpt

Autism spectrum disorder (ASD) is a common neurodevelopmental condition for which there are no pharmacological therapies that effectively target its core symptomatology. Animal models of syndromic forms of ASD, such as neurofibromatosis type 1, may be of use in screening for such treatments. Drosophila larvae lacking Nf1 expression exhibit tactile hypersensitivity following mechanical stimulation, proposed to mi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ddd1d65-3b71-5d0c-ace3-4bf6792f2f8c
DOI
10.1101/2022.11.11.516139
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A targeted, low-throughput compound screen in a <i>Drosophila</i> model of neurofibromatosis type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD)DOI 10.1101/2022.11.11.516139
Select a neighboring publication to make it the new centre.